179 related articles for article (PubMed ID: 20628057)
1. Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors.
Ingalla EQ; Miller JK; Wald JH; Workman HC; Kaur RP; Yen L; Fry WH; Borowsky AD; Young LJ; Sweeney C; Carraway KL
J Biol Chem; 2010 Sep; 285(37):28691-7. PubMed ID: 20628057
[TBL] [Abstract][Full Text] [Related]
2. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
[TBL] [Abstract][Full Text] [Related]
3. Oligomerization of the Nrdp1 E3 ubiquitin ligase is necessary for efficient autoubiquitination but not ErbB3 ubiquitination.
Printsev I; Yen L; Sweeney C; Carraway KL
J Biol Chem; 2014 Mar; 289(12):8570-8. PubMed ID: 24519943
[TBL] [Abstract][Full Text] [Related]
4. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling of PI3K from ErbB3 impairs mammary gland development but does not impact on ErbB2-induced mammary tumorigenesis.
Lahlou H; Müller T; Sanguin-Gendreau V; Birchmeier C; Muller WJ
Cancer Res; 2012 Jun; 72(12):3080-90. PubMed ID: 22665265
[TBL] [Abstract][Full Text] [Related]
6. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
[TBL] [Abstract][Full Text] [Related]
7. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
[TBL] [Abstract][Full Text] [Related]
8. The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3.
Hatakeyama J; Wald JH; Rafidi H; Cuevas A; Sweeney C; Carraway KL
Sci Signal; 2016 Jun; 9(434):ra65. PubMed ID: 27353365
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1.
Cao Z; Wu X; Yen L; Sweeney C; Carraway KL
Mol Cell Biol; 2007 Mar; 27(6):2180-8. PubMed ID: 17210635
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
Luhtala S; Staff S; Kallioniemi A; Tanner M; Isola J
BMC Cancer; 2018 Oct; 18(1):1045. PubMed ID: 30367623
[TBL] [Abstract][Full Text] [Related]
11. Quantity control of the ErbB3 receptor tyrosine kinase at the endoplasmic reticulum.
Fry WH; Simion C; Sweeney C; Carraway KL
Mol Cell Biol; 2011 Jul; 31(14):3009-18. PubMed ID: 21576364
[TBL] [Abstract][Full Text] [Related]
12. Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3.
Qiu XB; Goldberg AL
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14843-8. PubMed ID: 12411582
[TBL] [Abstract][Full Text] [Related]
13. ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer.
Stern DF
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):215-23. PubMed ID: 18454306
[TBL] [Abstract][Full Text] [Related]
14. Nrdp1 expression to predict clinical outcome and efficacy of adjuvant anthracyclines-based chemotherapy in breast cancer: A retrospective study.
Jiao S; Liu W; Wu M; Peng C; Tang H; Xie X
Cancer Biomark; 2015; 15(2):115-23. PubMed ID: 25519010
[TBL] [Abstract][Full Text] [Related]
15. Nrdp1 is involved in hippocampus apoptosis in cardiopulmonary bypass-induced cognitive dysfunction via the regulation of ErbB3 protein levels.
Zheng J; Min S; Hu B; Liu Q; Wan Y
Int J Mol Med; 2019 Apr; 43(4):1747-1757. PubMed ID: 30720051
[TBL] [Abstract][Full Text] [Related]
16. An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels.
Diamonti AJ; Guy PM; Ivanof C; Wong K; Sweeney C; Carraway KL
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2866-71. PubMed ID: 11867753
[TBL] [Abstract][Full Text] [Related]
17. Nrdp1-mediated ErbB3 degradation inhibits glioma cell migration and invasion by reducing cytoplasmic localization of p27(Kip1).
Shi H; Gong H; Cao K; Zou S; Zhu B; Bao H; Wu Y; Gao Y; Tang Y; Yu R
J Neurooncol; 2015 Sep; 124(3):357-64. PubMed ID: 26088461
[TBL] [Abstract][Full Text] [Related]
18. Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.
Young CD; Nolte EC; Lewis A; Serkova NJ; Anderson SM
Breast Cancer Res; 2008; 10(4):R70. PubMed ID: 18700973
[TBL] [Abstract][Full Text] [Related]
19. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD
Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
[TBL] [Abstract][Full Text] [Related]
20. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.
Holbro T; Beerli RR; Maurer F; Koziczak M; Barbas CF; Hynes NE
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8933-8. PubMed ID: 12853564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
